Skip to content

PRESS RELEASES


PRESS RELEASES

Date Title and Summary Additional Formats
Toggle Summary Integra LifeSciences Completes the Acquisition of Codman Neurosurgery Business from Johnson & Johnson
PLAINSBORO, N.J., Oct. 02, 2017 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART), a global leader in medical technology, announced today that it has completed the previously announced acquisition of the Johnson & Johnson Codman Neurosurgery business for approximately
View HTML
Toggle Summary Integra LifeSciences Provides Preliminary Assessment of Minor Damage to its Manufacturing Facility in Añasco, Puerto Rico
PLAINSBORO, N.J., Sept. 26, 2017 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced that its manufacturing facility in Añasco, Puerto Rico sustained relatively minor damage from the impact of Hurricane Maria.  A
View HTML
Toggle Summary Integra LifeSciences Announces First Patient Enrolled in Cadence® Total Ankle System Post-Market Study
PLAINSBORO, N.J., Sept. 21, 2017 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced the first Cadence ® Total Ankle System has been implanted by Dr. David Pedowitz with the Rothman Institute in Philadelphia,
View HTML
Toggle Summary Integra LifeSciences Announces Definitive Agreement to Sell Certain Neurosurgery Assets to Natus Medical Incorporated
Natus Medical to acquire global Camino® ICP monitoring product line, U.S. rights to Integra's fixed pressure shunts, and U.S. rights to Codman's DURAFORM®, EVD catheters and CSF collection systems Integra is providing a preliminary estimate for a fourth quarter 2017 revenue contribution of
View HTML
Toggle Summary Integra LifeSciences to Present at Healthcare Conferences in September 2017
PLAINSBORO, N.J., Aug. 17, 2017 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, will present at the Wells Fargo Healthcare Conference and the Morgan Stanley Healthcare Conference in September.
View HTML
Toggle Summary Integra's DuraSeal® dural sealant saves healthcare costs according to a study recently published in the Journal of Health Economics and Outcomes Research
Hospitals can reduce costs of cerebrospinal fluid (CSF) leaks after posterior fossa surgeries by using DuraSeal® instead of fibrin glue
View HTML
Toggle Summary Integra LifeSciences Reports Second Quarter 2017 Financial Results
Revenue Increased 13.2% to $282.2 million ; Organic Revenue Increased 4.6%  Reported EPS of $0.14 ; Adjusted EPS of $0.45, up 12.5% PLAINSBORO, N.J., July 26, 2017 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today
View HTML
Toggle Summary Integra LifeSciences to Host Its Second Quarter 2017 Earnings Results Conference Call on July 26, 2017
PLAINSBORO, N.J., July 11, 2017 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, will release its second quarter 2017 financial results on Wednesday, July 26, 2017. In conjunction with the earnings release, the company will
View HTML
Toggle Summary Integra LifeSciences to Hold Second International Tissue Technologies Symposium on June 15 - 16, 2017 in Berlin, Germany
PLAINSBORO, N.J., June 15, 2017 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) today announced that it is holding its second International Symposium on Tissue Technologies in Berlin, Germany on June 15 - 16, 2017. Following the success of the first International Tissue
View HTML
Toggle Summary Integra LifeSciences to Present at Healthcare Conferences in June 2017
PLAINSBORO, N.J., May 24, 2017 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced that it will present at the following conferences in June: At 4:00PM ET on Wednesday, June 7, 2017, Mr.
View HTML
Toggle Summary Integra LifeSciences Announces Agreement with aap to Distribute LOQTEQ® Distal Radius System
PLAINSBORO, N.J. and BERLIN, May 23, 2017 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation  (Nasdaq:IART), a leading global medical technology company, announced today that it has signed an agreement with aap Implantate AG (" aap ") to distribute the LOQTEQ® Distal Radius System within
View HTML
Toggle Summary Integra LifeSciences Announces the European Launch of Integra® Dermal Regeneration Template Single Layer "Thin"
PLAINSBORO, N.J., May 17, 2017 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation  (Nasdaq:IART), a leading global medical technology company, today announced that it has launched in Europe Integra ®  Dermal Regeneration Template (IDRT) Single Layer "Thin" for dermal repair defects
View HTML
Toggle Summary Integra LifeSciences launches SurgiMend® MP Collagen Matrix for Hernia Repair
SurgiMend MP is a collagen matrix for soft tissue reconstruction, featuring a highly macroporous design
View HTML
Toggle Summary Integra LifeSciences to Present at Healthcare Conferences in May 2017
PLAINSBORO, N.J., May 03, 2017 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today announced that it will present at the following conferences in May: At 10:40AM PT on Tuesday, May 16, 2017, Mr.
View HTML
Toggle Summary Integra LifeSciences Reports First Quarter 2017 Financial Results
Revenue Increased 9.2% to $258.6 million; Organic Revenue Increased 6.4%  Reported EPS of $0.08; Adjusted EPS of $0.39 PLAINSBORO, N.J., April 26, 2017 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today reported its
View HTML